BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7030300)

  • 21. Platelet-endothelial cell interactions. Metabolic maps of structures and actions of prostaglandins, prostacyclin, thromboxane and cyclic AMP.
    Nalbandian RM; Henry RL
    Semin Thromb Hemost; 1978; 5(2):87-111. PubMed ID: 216078
    [No Abstract]   [Full Text] [Related]  

  • 22. The action of non-steroidal antiinflammatory agents on platelet aggregation and vessel tone in relation to inhibition of PGI2- and thromboxane-release. With particular reference to 5-benzoyl-alpha-methyl-2-thiophene acetic acid (tiaprofenic acid).
    Kuhn A; Sauerland S; Schiffer K; Schrör K
    Arzneimittelforschung; 1980; 30(9):1538-42. PubMed ID: 7006618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of gefarnate on endogenous prostacyclin, prostaglandin E2 and thromboxane in water-immersed rats.
    Kobayashi K; Arakawa T; Nakamura H; Chono S; Yamada H; Satoh H; Ono T
    Tohoku J Exp Med; 1983 Jun; 140(2):181-5. PubMed ID: 6351352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased prostacyclin release from perfused hearts of acutely diabetic rats.
    Rösen P; Schrör K
    Diabetologia; 1980 May; 18(5):391-4. PubMed ID: 7000593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of arachidonic acid and bradykinin on the coronary flow, release of PGI2 and cardiac functions in the perfused guinea-pig heart.
    Terashita Z; Fukui H; Nishikawa K; Hirata M; Kikuchi S
    Jpn J Pharmacol; 1982 Apr; 32(2):351-8. PubMed ID: 7047826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethanol inhibits platelet thromboxane A2 production but has no effect on lung prostacyclin synthesis in humans.
    Toivanen J; Ylikorkala O; Viinikka L
    Thromb Res; 1984 Jan; 33(1):1-8. PubMed ID: 6364450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
    Moncada S; Vane JR
    Drug Ther; 1982; ():37-65. PubMed ID: 7049651
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin treatment normalises the arachidonic acid induced prostacyclin release from the platelet perfused diabetic rat heart. Evidence for major changes in 15-hete production.
    Bresser HJ; Rösen P; Schrör K
    Prog Clin Biol Res; 1987; 242():143-8. PubMed ID: 3118378
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic fate of thromboxane A2 and prostacyclin.
    Roberts LJ; Brash AR; Oates JA
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():211-25. PubMed ID: 6216783
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo and ex vivo studies of the effect of vitamin E pre-treatment on PGI2 and TXA2 synthesis.
    Förster W
    Acta Med Scand Suppl; 1980; 642():47-8. PubMed ID: 7006327
    [No Abstract]   [Full Text] [Related]  

  • 31. Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart.
    Sakai K; Ito K; Ogawa K
    J Cardiovasc Pharmacol; 1982; 4(1):129-35. PubMed ID: 6176788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
    Tanabe M; Terashita Z; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and metabolism of prostaglandins, prostacyclin, and thromboxanes: the arachidonic acid cascade.
    Ramwell PW; Foegh M; Loeb R; Leovey EM
    Semin Perinatol; 1980 Jan; 4(1):3-13. PubMed ID: 6247764
    [No Abstract]   [Full Text] [Related]  

  • 34. Elevated glucose in vivo and in vitro adversely alters prostaglandin generation in rat aortas and platelets.
    Valentovic MA; Lubawy WC
    Prostaglandins Leukot Med; 1985 Sep; 19(3):271-7. PubMed ID: 3903777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sevoflurane and isoflurane do not enhance the pre- and postischemic eicosanoid production in guinea pig hearts.
    Heindl B; Becker BF
    Anesth Analg; 2000 Jan; 90(1):17-24. PubMed ID: 10624969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostacyclin and thromboxane in thrombosing atherosclerotic diseases].
    Viinikka L
    Duodecim; 1981; 97(13):925-7. PubMed ID: 7032876
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of prostaglandins and thromboxane A2 on the coronary circulation of adult dogs and puppies.
    Wang HH; Kulkarni PS; Eakins KE
    Eur J Pharmacol; 1980 Aug; 66(1):31-41. PubMed ID: 7408964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 39. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of labile cyclo-oxygenase products of arachidonic acid from kidney by endotoxin.
    Ozsan K; Içöz V; Türker RK
    Experientia; 1984 Aug; 40(8):815-6. PubMed ID: 6432573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.